<DOC>
	<DOCNO>NCT00948298</DOCNO>
	<brief_summary>Vitamin D natural nutrient . A little come normal daily diet . Most come skin sunlight . If darker skin , make less vitamin D. Vitamin D balance calcium body . If vitamin D level get low cause health problem . It may increase chance get high blood pressure diabetes . Another problem may vitamin D level low blood vessel may work normally . These important health problem anyone . Because African Americans darker skin , likely racial/ethnic group low vitamin D level . This study look treating African Americans low vitamin D level . The goal study see vitamin D help blood vessel work . The investigator study African Americans overweight , high blood pressure low vitamin D level . The investigator see get vitamin D level normal value improve blood vessel work . The dose vitamin D give study high dose give people low vitamin D level .</brief_summary>
	<brief_title>Effect Vitamin D3 Vascular Function</brief_title>
	<detailed_description>Cardiovascular Disease ( CVD ) relate disorder remain leading cause death nation . Hypovitaminosis D link several cardiovascular ( CV ) risk factor include hypertension , diabetes , obesity also increase rate CVD . Thus , hypovitaminosis D present common pathway select subgroup cluster CV risk factor profile predominant among ethnic minority . Indeed , hypovitaminosis D highly prevalent estimate 55 % US adult population level 30 ng/ml , 80 % African Americans suboptimal value . Thus , propose twelve week randomize double-blind , placebo control pilot trial ass effect vascular function CV risk factor 100,000 IU Vitamin D3 give every 4 week overweight , hypertensive African-Americans hypovitaminosis D. To knowledge , propose project first assess effect 'high-dose ' Vitamin D3 administration vascular function.We believe study also first examine impact molecular level Vitamin D3 repletion key mediator cardio-metabolic pathway human . If study result support work hypothesis , position propose large scale study detect therapeutic effect definitive , clinical cardiovascular endpoint across diverse population .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Males female , 1870 year age selfidentified AfricanAmerican Black Hypertension If potential study patient treatment SBP must &gt; 130 mmHg , DBP &gt; 85 mmHg , SBP must &lt; 160 mmHg DBP must &lt; 105 mmHg . If potential study patient treatment SBP must &lt; 160 mmHg DBP must &lt; 105 mmHg Screening Vitamin D ( D2 D3 level ) 10 25 ng/ml ( normal level &gt; 30 ng/ml ) Body mass index ( BMI ) &gt; 25 kg/m2 Poorly control high blood pressure ( SBP &gt; 160 mmHg DBP &gt; 105 mmHg ) Diabetes ( fast blood sugar &gt; 125 mg/dl , HbA1c &gt; 6.5 % ) Screening Vitamin D ( D2 D3 level ) &lt; 10 ng/ml &gt; 25 ng/ml Estimated glomerular filtration rate ( eGFR ) &lt; 45 ml/min Evidence disease result hypercalcemia History kidney stone History drug , alcohol , illicit substance abuse within past 6 month History another chronic disease investigator feel preclude subject enter study Liver function test ( LFTs ) great twice upper limit normal Subjects require chronic use nonsteroidal antiinflammatory drug , aspirin , drug may affect measurement reactive oxidative specie Subjects require treatment vitamin D preparation contain 400 IU vitamin D Subjects require chronic use immunosuppressive therapy corticosteroid Recent ( &lt; 6 month ) myocardial infarction , stroke , hospitalization congestive heart failure Allergy/intolerance : know allergy oral vitamin D microcrystalline cellulose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>cardiovascular disease</keyword>
	<keyword>vitamin D</keyword>
	<keyword>african american</keyword>
	<keyword>low vitamin D level</keyword>
</DOC>